Frontiers in Molecular Neuroscience (FMN)

Frontiers in Molecular Neuroscience is a PubMed Central, Scopus, and SCIE-indexed journal, that explores the brain's molecular structure, design, and function. Frontiers in Molecular Neuroscience is led by Field Chief Editors Robert J. Harvey (University of the Sunshine Coast, Queensland, Australia) and Jochen C. Meier (Technische Universitat Braunschweig, Germany). This multidisciplinary journal seeks to identify how key molecules function and interact to understand the brain's structure, design, and function across all levels. Topics of interest include: brain disease mechanisms coding and non-coding RNA methods and model organisms molecular mechanisms regulating cellular and dendritic RNA trafficking and translation molecular signaling and pathways neuroplasticity and development pain mechanisms and modulators synaptic and cellular proteins. Frontiers in Molecular Neuroscience is particularly interested in submissions on human brain diseases, and genetically engineered model organisms – such as C. elegans, Drosophila, zebrafish, and rodents – in which alterations in key molecules underlying cellular and synaptic function and plasticity produce defined anatomical, physiological or behavioral changes. Research on genetic alterations in specific neural circuits (e.g., olfactory bulb, motor cortex, cortical layers, hippocampal subfields, cerebellum, brainstem, spinal cord) and compensatory or homeostatic mechanisms are of particular interest. Equally important, the journal encourages submissions that advance the UN's Sustainable Development Goals (SDGs), specifically SDG 3: good health and well-being, promoting our biological understanding of brain health. Manuscripts that focus on clinical practice, genetics, neurological function, cognitive function, and cell proliferation without a clear connection to molecular neuroscience are not suitable for publication in this journal. Similarly, studies on complementary/alternative medicine, e.g., acupuncture/electroacupuncture will not be considered. Studies that do not provide novel insights into the molecular mechanisms underlying neurological processes are also out of scope. For example, research on stem cells or genetic causes of disease without a direct link to molecular neuroscience will not be considered. Frontiers in Molecular Neuroscience is also committed to advancing research in the field of molecular neuroscience by allowing unrestricted access to articles and communicating scientific knowledge to researchers and the public to enable future scientific breakthroughs.

Frontiers in Molecular Neuroscience (FMN) is :-

• International, Peer-Reviewed, Open Access, Refereed, multidisciplinary, Brain Disease Mechanisms, Methods and Model Organisms, Molecular Neuroscience Archive, Molecular Signalling and Pathways, Neuroplasticity and Development, Pain Mechanisms, Modulators, Molecular Biology, Neuroscience, Molecular Neuroscience, Neurosciences , Online , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 1662-5099, Established: 2025, Impact Factor: 3.5
• Provides Crossref DOI

• Indexed in: Scopus, WoS, DOAJ, PubMed

• Not indexed in UGC CARE